Editorial Board: Journal of Neurosurgery
Gregory J. Zipfel, MD Co-Chair
Dr. Gregory J. Zipfel was born and raised in Peoria, Illinois. He received his BS from the University of Illinois in 1991 and his MD with distinction from Northwestern University in 1995. He completed a neurosurgery residency at the University of Florida under the mentorship of Drs. Albert Rhoton and Arthur Day and a cerebrovascular and skull base surgery fellowship at the University of Miami under the mentorship of Drs. Roberto Heros and Jacques Morcos. He also completed a post-doctoral research fellowship at Washington University in St. Louis in the ischemic brain injury laboratory of Dr. Dennis Choi. He joined the faculty at Washington University in St. Louis as an assistant professor in 2004, was named Co-Director of the Stroke and Cerebrovascular Center in 2008, was promoted to Associate Professor and Residency Program Director in 2011, and was promoted to full professor in 2015.
Dr. Zipfel focuses his clinical practice on the surgical management of cerebrovascular disease and skull base tumors. He also directs the Cerebrovascular Research Program in the Department of Neurosurgery at Washington University – a program that includes both basic, translational, and clinical studies focusing on three primary areas: 1) Examining the pathophysiologic effects of amyloid-β peptide (Aβ) and cerebral amyloid angiopathy on cerebral arteriole function, cerebral blood flow, ischemic brain injury, and cerebral hemorrhage and the manner by which these deleterious cerebrovascular effects contribute to dementia; 2) Exploring the molecular basis and applying novel therapeutic approaches to prevent and/or reduce early brain injury and delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage; and 3) Determining and classifying the pathophysiology, natural history, and optimal treatment of dural arteriovenous fistulae. He is the author of over 150 peer-reviewed publications and has held continuous NIH funding since 2005.
Dr. Zipfel joined the Editorial Board of the Journal of Neurosurgery in 2013.
Theodore H. Schwartz, MD Co-Chair
Dr. Theodore H. Schwartz received his undergraduate and medical degrees from Harvard University where he graduated Magna Cum Laude. After completing his residency and chief residency in Neurosurgery at The Neurological Institute of New York at Columbia-Presbyterian Medical Center, Dr. Schwartz completed advanced fellowship training at Yale-New Haven Medical Center in the surgical treatment of brain tumors and epilepsy. Dr. Schwartz specializes in image-guided minimally invasive surgery such as endoscopy, stereotaxis, microsurgery and intraoperative brain mapping. He has received numerous awards and fellowships including the prestigious van Wagenen Fellowship, awarded by the American Association of Neurological Surgeons and the von Humboldt Fellowship, awarded by the German Government.
Dr. Schwartz is a Professor of Neurosurgery, Otolaryngology, Neurology and Neuroscience at Weill Cornell Medical College, New York Presbyterian Hospital, and the Director of Epilepsy and Pituitary Surgery, Director of the Institute for Minimally Invasive Skull Base and Pituitary Surgery Program and the Co-Director of Surgical Neuro-Oncology. He is also the director of a research laboratory investigating novel techniques for imaging and treating epilepsy, which is funded by several private organizations as well as the National Institutes of Health, where he has also served on several grant review committees.
Dr. Theodore H. Schwartz has provided commentary for numerous television shows on ABC, NBC and CBS as well as appeared on Larry King on several occasions in addition to national radio shows. His expertise has been sought through interviews, quoted and published, in the Wall Street Journal, The New York Post, The New York Daily News, Crain's New York Business and he has been asked to lecture throughout the country and world. His work has been published in numerous peer reviewed basic science and clinical journals such as the Journal of Neurosurgery, Neurosurgery, Epilepsia, the Journal of Neuro-Oncology, Nature Medicine, NeuroImage, the Journal of Neuroscience the Journal of Neurophysiology and the Journal of Cerebral blood Flow and Metabolism. He is on the editorial board of Journal of Neurosurgery, World Neurosurgery, Epilepsy Research and Treatment, and Epilepsy Currents. He has been named one of New York’s Superdoctors, New York Magazine’s Best Doctors and America’s Best Surgeons for several years. He has co-authored two textbooks entitled “Practical Endoscopic Skull Base Surgery” and “Endoscopic Pituitary Surgery” and lectures and teaches both Nationally and Internationally including recent lectures in China, Brazil, Singapore, India, Canada, Mexico and Austria. He was elected to the Editorial Board of Journal of Neurosurgery in 2013.
Aaron S. Dumont, MD Co-Chair
Dr. Aaron Dumont is currently the Charles B. Wilson Professor and Chair of the Department of Neurosurgery at Tulane University. He grew up in Abbotsford, British Columbia, Canada and attended the University of British Columbia in Vancouver for his undergraduate studies. He completed medical school at the University of Calgary. He completed his residency training at the University of Virginia under the tutelage of Drs. John Jane, Sr., Neal Kassell, Edward Laws, Ladislau Steiner and Mark and Chris Shaffrey, among others. He was especially grateful that Dr. Jane was willing to take a young, unknown medical student from Canada into his prestigious training program. He subsequently completed a fellowship in cerebrovascular, endovascular and skull base surgery at the University of Virginia. He was on faculty at the University of Virginia for three years prior to moving to Thomas Jefferson University in Philadelphia where he worked under the leadership of Dr. Robert Rosenwasser. He was promoted to Professor of Neurosurgery and Director of the Division of Cerebrovascular and Endovascular Surgery (comprised of 10 dual-trained neurosurgeons at 5 practice sites).
Dr. Dumont’s clinical and research interests have traditionally focused on cerebral vascular disease and stroke, although he maintains interests in all areas of adult and pediatric neurosurgery. He has been awarded research support from the American Heart Association and was the recipient of the Charles Elsberg Fellowship from the New York Academy of Medicine as well as a young Clinician Investigator Award from the Neurosurgery Research and Education Foundation. He is currently funded by a K08 award from the National Institute of Neurological Disorders and Stroke for the investigation of the role of TNF-alpha in the formation, progression and rupture of cerebral aneurysms. His laboratory is actively investigating molecular mechanisms underlying the pathogenesis of cerebral aneurysms with the goal of developing novel minimally invasive or non-invasive therapies. He also has research interests in endovascular device and technology development. He has over 200 scientific publications and currently serves on the Editorial Boards of 11 journals (including Stroke since 2005).
Dr. Dumont is committed to medical student, resident and fellow education, which is undoubtedly a product of the mentorship during his training. He is currently assembling a faculty committed to the same and specifically to training the next generation of neurosurgeons who will “Carry the Message”.
Dr. Dumont was elected to the Editorial Board of the Journal of Neurosurgery in 2014.
Bob Carter, MD, PhD
Dr. Bob Carter is currently Professor and Chief of Neurosurgery at the Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts. He completed his B.A. with University Honors in Chemistry at Brigham Young University, his M.D. with AOA distinction at the Johns Hopkins School of Medicine, and his Ph.D. in genetic epidemiology at the Johns Hopkins School of Public Health. Dr. Carter trained in Neurosurgery at the Massachusetts General Hospital under Dr. Nick Zervas and remained on the faculty with Dr. Robert Martuza until he was recruited to UC San Diego in 2010 as Professor and Chair. While at UC San Diego, Dr. Carter led the formation of the UC San Diego Neurological Institute and co-directed the UCSD Brain Tumor Center. In 2017, Dr. Carter was recruited back to MGH to lead the Department of Neurosurgery, where he specializes in the treatment of brain tumors and complex intracranial surgery including cerebral bypass and aneurysm surgery. He lectures nationally and internationally on neurosurgery topics and was past editor of the General Neurosurgery section of Neurosurgery.
The NIH has continuously funded Dr. Carter's research since 2000. His doctoral work focused on cancer genetics, and he completed a post-doctoral fellowship in gene therapy at the Massachusetts Institute of Technology/Whitehead Institute. He has published over 100 papers on diverse topics including improving outcomes for intracranial surgery and the development of gene transfer delivery techniques for the central nervous system. In recent years, his work on exosomes has led to new insights regarding the use of extracellular RNA for biomonitoring of brain tumors and other neurological disorders.
Dr. Carter has been actively engaged in organized neurosurgery as a member of Congress of Neurological Surgeons, the American Association of Neurological Surgeons, the American Academy of Neurological Surgery and the Society of Neurological Surgeons. He has also served on the executive boards of the Joint Cerebrovascular section, the New England Neurosurgical Society and the California Association of Neurological Surgeons.
Dr. Carter joined the Editorial Board of the Journal of Neurosurgery in 2014.
Frederick Barker II, MD
Dr. Barker received his undergraduate degree in biochemistry and classical civilization from Yale College and a medical degree from Harvard. He completed a neurosurgery residency at Massachusetts General Hospital, followed by fellowships at University of Pittsburgh (microvascular and skull base) and UCSF (neuro-oncology). Since 1995 he has practiced at Massachusetts General Hospital, focusing on posterior fossa tumor surgery and microvascular decompression.
Research interests have included brain tumor clinical trial design in the ACOSOG, RTOG/NRG and Alliance cancer cooperative groups and the NABTT and ABTC cancer consortia. He currently sits on the NCI/CTEP Brain Malignancies Steering Committee. He has served on the Scientific Program Committee of the AANS, CNS and the Academy.
Dr. Barker joined the Editorial Board of the Journal of Neurosurgery in 2015.
Nicholas C. Bambakidis, MD
Nicholas C. Bambakidis, MD, is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the North American Spine Society, and the North American Skull Base Society and was voted into the Society of Neurological Surgeons at the annual meeting in Atlanta in 2012. He is board certified by the American Board of Neurological Surgery.
While completing his residency in Neurological Surgery at University Hospitals and MetroHealth Medical Center, Dr. Bambakidis participated in extensive training in the treatment of aneurysms and carotid artery disease as well as primary and metastatic tumors of the brain and skull base. Following his residency, he completed Fellowship training with Volker Sonntag, MD, and Robert F. Spetzler, MD, at the Barrow Neurological Institute (BNI), focusing on the treatment of cerebrovascular disease and skull base tumors as well as complex spinal disorders. After his Fellowship training, he stayed at the BNI as an Assistant Professor of Neurosurgery, with a joint appointment at the University of Arizona School of Medicine.
In 2008, he was recruited by the University Hospitals Neurological Institute to serve as Director of the Cerebrovascular and Skull Base Surgery Center. He is currently Professor of Neurological Surgery at Case Western Reserve University School of Medicine. At the end of 2011, he was appointed Program Director of the School’s residency program.
During his academic career, Dr. Bambakidis has authored more than 50 publications on a broad array of topics in his field of expertise and edited two major textbooks—one on skull base surgery and a second on surgery of the craniovertebral junction, for which he served as the primary editor. He has actively pursued cutting-edge research on the ability of the central nervous system to recover after injury and is the author of several basic science papers on this subject.
Believing that patients should be equal partners in their care while trusting in the expertise and experience of their neurosurgical team, Dr. Bambakidis’ philosophy of patient care is to be compassionate yet direct. Patients with complex neurological disorders deserve to be presented with all available treatment options, he feels, and then be given a concrete opinion regarding the best and safest therapeutic option for them.
Dr. Bambakidis joined the Editorial Board of the Journal of Neurosurgery in 2015.
Kevin Cockroft, MD
Kevin M. Cockroft, MD, MSc, FAANS, FACS, FAHA is Director of Cerebrovascular and Endovascular Neurosurgery in the Department of Neurosurgery at the Penn State Milton S. Hershey Medical Center and Pennsylvania State University College of Medicine. He is also co-Director of the Penn State Hershey Stroke Center and Director of the Neurosurgery Department’s Neuroendovascular Fellowship Training Program. Dr. Cockroft holds the academic rank of professor with joint appointments in Neurosurgery, Radiology and Public Health Sciences. Dr. Cockroft received his undergraduate education at The Johns Hopkins University and his MD degree from Cornell University. He did his residency training at The New York Presbyterian Hospital-Cornell Medical Center. Dr. Cockroft completed fellowship training in neurovascular microsurgery at Stanford University and endovascular neurosurgery (interventional neuroradiology) at Thomas Jefferson University. He also holds a Master of Science degree in Public Health Sciences from Penn State University.
Dr. Cockroft’s clinical and research interests include, brain aneurysms and subarachnoid hemorrhage, as well as AVMs of the central nervous system and occlusive cerebrovascular disease. He is or has been the principal investigator on several clinical trials and he has been an author or co-author on numerous scientific articles and book chapters. He has previously served as the President of the Pennsylvania Neurosurgical Society. He is currently Chair of the AANS/CNS Joint Guidelines Committee and Chair-Elect of the Joint Cerebrovascular Section of the AANS/CNS. He also serves on the board of directors of the Intrasocietal Commission for the Accreditation of Carotid Stenting Facilities. Dr. Cockroft has had the honor of being named to the Consumers’ Research Council of America’s Guide to America’s Top Physicians & Surgeons and Best Doctors Incorporated’s Best Doctors in America.
Dr. Cockroft joined the Editorial Board of the Journal of Neurosurgery in 2015.
Randy Jensen, MD, PhD
Dr. Randy Jensen is currently Professor of Neurosurgery, Radiation Oncology and Oncological Sciences at the University of Utah. He serves as Residency Program Director. He completed a dual major in Chemistry and Biology at the University of Utah. He and his wife Elizabeth were classmates at the University of Utah School of Medicine. Upon graduation he began a residency in Neurological Surgery at Loyola University of Chicago. During this time he was awarded a Ph.D. in Neuroscience with research emphasis on meningioma signal transduction and biology. Following residency, he accepted a faculty position at the University of Utah where he as been since 1998.
Dr. Jensen co-directs the brain tumor group at the Huntsman Cancer Institute. His clinical work focuses in the surgical management of intracranial tumors and stereotactic radio surgery. He has special interest in preoperative and intraoperative cortical mapping and imaging for resection of tumors in eloquent areas of the brain. His laboratory interests are the role of hypoxia in brain tumor growth and angiogenesis, animal models of pseudo progression, and preclinical models of meningioma. He has authored over 130 peer-reviewed scientific and clinical publications. He has received the Journal of Neuro-oncology Award, the CNS Mahaley Clinical Research Award, and the Tumor Young Investigator Award.
Dr. Jensen has been involved in organized neurosurgery serving on a number of committees for the American Association of Neurological Surgeons, executive board of the Joint Tumor Section, and past president of the Rocky Mountain Neurosurgery Society. He has directed the Lende Winter Neurosurgery Meeting for the past 10 years. He has served on the editorial boards of Neuro Oncology, Surgical Neurology International, Journal of Radiosurgery and SBRT, and Contemporary Neurosurgery. He has been an ad hoc reviewer for an additional 25 journals, the NIH and American Cancer Society.
Dr. Jensen joined the Editorial Board of the Journal of Neurosurgery in 2015.
Michael A. Vogelbaum, MD, PhD
Michael A. Vogelbaum, MD, PhD, is Professor of Neurosurgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Associate Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BTNC) and Director of the BTNC’s Center for Translational Therapeutics at the Cleveland Clinic, where he holds the Robert W. and Kathryn B. Lamborn Chair in Neuro-Oncology. He received his MD and PhD (Biomedical Engineering) from University of Virginia and completed his residency in neurosurgery at Barnes-Jewish Hospital/Washington University in St. Louis.
In addition to his active neurosurgery and radiosurgery practice, Dr. Vogelbaum has been primary investigator of numerous local and national clinical trials of new drugs and surgical techniques and devices for brain tumors. He has an externally funded basic science and translational research laboratory that currently focuses on immunobiology of brain tumors and on various aspects of drug delivery to brain tumors. He is currently developing novel devices for delivering therapeutics directly to the brain, for which he has received multiple patents. The first of these devices has been introduced into clinical trials. He is the co-founder and chief medical officer of Infuseon Therapeutics, Inc., a company that was spun-off from Cleveland Clinic Innovations to commercialize his therapeutic delivery devices.
Dr. Vogelbaum is a founder of the RANO (Response Assessment in Neuro-Oncology) group, chair of the Neurosurgery Committee for NRG Oncology, and he has been a vice president of the Society for NeuroOncology. He is a member of the editorial board for the journals Neuro-Oncology and Neurosurgery, Tumor Section co-editor of World Neurosurgery and he is co-editor of the comprehensive textbook on neuro-oncology, Principles and Practice of Neuro-Oncology (2011).
Dr. Vogelbaum joined the Editorial Board of the Journal of Neurosurgery in 2016.
Michael G Kaplitt, MD, PhD
Michael G. Kaplitt, MD, PhD received his undergraduate degree in molecular biology magna cum laude from Princeton University, where he also received a certificate of proficiency in Russian studies. He went on to complete a PhD in molecular neurobiology from The Rockefeller University, followed his MD from Cornell University Medical College. After his neurological surgery residency at NewYork-Presbyterian Hospital, he completed a fellowship in stereotactic and functional neurosurgery at the University of Toronto. He then joined the faculty at Weill Cornell Medical College, where he is currently vice-chairman for Research and Residency Director in the Department of Neurological Surgery.
Dr. Kaplitt has long been a leader in the field of gene therapy, having written the seminal paper in the field in 1994, demonstrating the effectiveness of adeno-associated virus as a gene transfer agent in the brain. In 2003, he performed the first adult human in vivo gene therapy for neurological disease, and he directed the first successful randomized, double-blind study of CNS gene therapy in 2011. He has been NIH funded throughout most of his career, in addition to receiving funding from the Department of Defense, Michael J. Fox Foundation, JPB Foundation, and many other major private foundations. His current research interests focus on using novel gene therapy approaches to understand and treat Parkinson’s disease, depression, drug addiction, and pain. He is clinically active as Director of Stereotactic and Functional Neurosurgery, focusing primarily upon the treatment of movement disorders, pain, and hydrocephalus, and he has directed or participated in several clinical trials in these areas. He was a full member of the NINDS NSD-K clinical trials study section and is an elected member of the American Society for Clinical Investigation and the Society for Neurological Surgeons.
Dr. Kaplitt joined the Editorial Board of the Journal of Neurosurgery in 2016.
Howard A. Riina, MD
Dr. Howard A. Riina is Professor of Neurosurgery, Neurology and Radiology; Vice Chair of the Department of Neurosurgery; Director of the Neurosurgery Residency Training Program; and Director of Endovascular Neurosurgery at New York University School of Medicine and NYU Langone Medical Center. He was born in Brooklyn, New York. He received undergraduate degrees from both Franklin and Marshall College and the University of Pennsylvania in a dual-degree, 5-year bioengineering program in 1987. He graduated from Temple University School of Medicine in 1993. Between his third and forth years of medical school, he obtained an M.Phil. in biology (molecular neurobiology) from the University of Cambridge. He completed his surgical internship and trained in neurological surgery at the Hospital of the University of Pennsylvania with Drs. Eugene S. Flamm and M. Sean Grady. Dr. Riina has completed fellowship experience in Diagnostic Neuroradiology with Robert Grossman, M.D., at the Hospital of the University of Pennsylvania. In addition he completed two formal fellowships: interventional neuroradiology, with Alejandro Berenstein, M.D., at the Institute of Neurology and Neurosurgery Beth Israel Medical Center, and cerebrovascular and skull base surgery, with Robert F. Spetzler, M.D., at the Barrow Neurological Institute. In 2001, Dr. Riina was recruited to Weill Medical College of Cornell University, NewYork-Presbyterian, to perform both open cerebrovascular surgery and interventional neuroradiology; there he was Professor of Neurological Surgery and Radiology and Residency Program Director of the Department of Neurological Surgery. He was Co-Director of Interventional Neuroradiology at NewYork-Presbyterian prior to joining the faculty of the NYU School of Medicine.
Dr. Riina specializes in the surgical and endovascular treatment of cerebrovascular disorders of the brain and spinal cord. He has particular interest in the treatment of intracranial aneurysms and arteriovenous malformations of the brain and spinal cord. He has also been involved in new treatments for acute stroke. Most recent interests involve the development of new minimally invasive devices and treatments for cerebrovascular and skull base disorders as well as intraarterial chemotherapy for recurrent malignant brain tumors.
Dr. Riina joined the Editorial Board of the Journal of Neurosurgery in 2016.
Aviva Abosch, MD, PhD
A graduate of Bryn Mawr College, Dr. Aviva Abosch completed her MD and PhD (Neurobiology) at the University of Pittsburgh, her neurosurgery residency at the University of California, San Francisco (UCSF), and her fellowship training in epilepsy surgery at the Montreal Neurological Institute (McGill University, Montreal, QC), and in stereotactic and functional neurosurgery at the University of Toronto.
Dr. Abosch was a faculty member of the Neurosurgery Department at Emory University from 2002 to 2005 and the University of Minnesota in Minneapolis from 2005 to 2013; since July of 2013, she has been on the faculty at the University of Colorado-Anschutz Medical Campus, where she is a tenured Professor of Neurosurgery and Neurology, Vice Chair for Research for the Department of Neurosurgery, and Director of the Epilepsy and Stereotactic Surgery Program, as well as the fellowship training program.
Her research interests include high-field magnetic resonance imaging of the brain, and electrophysiological correlates of movement disorders, and she has been involved with a number of clinical trials relating to the surgical treatment of epilepsy, movement, and the neuropsychiatric disorders.
Dr. Abosch is a mentor to students, residents, and faculty both nationally and internationally. She is actively engaged in organized neurosurgery, and has served as President of the American Society of Stereotactic and Functional Neurosurgery (ASSFN), Scientific Program Committee Chair of the American Association of Neurological Surgeons (AANS), and President of Women in Neurosurgery (WINS). She is an associate editor of Stereotactic and Functional Neurosurgery, Journal of Neurology, Neurosurgery, and Psychiatry, Neuromodulation, and Neurosurgery, and speaks internationally on her areas of clinical and research expertise.
Dr. Abosch was elected to the Editorial Board of the Journal of Neurosurgery in 2017.
Michael Schulder, MD
Michael Schulder, MD, is the Director of the Brain Tumor Center and Vice-Chairman of Neurosurgery at Northwell Health, and Professor of Neurosurgery at the Hofstra Northwell University School of Medicine. He is the Neurosurgical Residency Program Director, and is the Co-Director of the Northwell Health Center for Stereotactic Radiosurgery and Radiation Therapy. He is the former Interim Director of Functional Neurosurgery at Northwell Health.
Dr. Schulder received his MD degree from the College of Physicians and Surgeons of Columbia University in 1982. He completed his residency training in neurosurgery at the Albert Einstein College of Medicine and trained in stereotactic neurooncology at Harvard Medical School and the University of Florida, and in functional neurosurgery at the Oregon Health Sciences University. Dr. Schulder has been the author of numerous peer-reviewed publications and book chapters, and he edited The Handbook of Stereotactic and Functional Neurosurgery. He is the current AANS Historian, the former editor of AANS Neurosurgeon, and an editorial board member of other neurosurgical peer-reviewed journals.
Dr. Schulder was elected to the Editorial Board of the Journal of Neurosurgery in 2017.
Louis J Kim, MD
Dr. Kim is currently Professor and Vice-Chair in the Department of Neurological Surgery at the University of Washington School of Medicine. He is also the Chief of Neurological Surgery at Harborview Medical Center and Associate Residency Program Director. He completed his undergraduate degree summa cum laude at Middlebury College, where he was elected to the Phi Beta Kappa Honor Society. He earned his medical degree at Columbia University College of Physicians & Surgeons with Alpha Omega Alpha honors. Under the tutelage of Drs. Robert Spetzler and Volker Sonntag, Dr. Kim completed his neurosurgery residency and fellowship training in both cerebrovascular/skull base and endovascular neurosurgery at Barrow Neurological Institute. After his clinical training, he joined the Department of Neurological Surgery at the University of Washington School of Medicine in Seattle under the mentorship of Richard Ellenbogen.
Dr. Kim’s clinical practice specializes in the microsurgical and endovascular treatment of aneurysms, AVMs, dural AV fistulas, cavernous malformations, moyamoya disease, and skull base tumors. He is passionate about translational research, including next-generation sequencing of cerebrovascular tissue in pursuit of the pathogenesis of brain aneurysms and AVMs; computation fluid dynamics modeling to predict the efficacy of aneurysm treatment; and novel clinical imaging techniques for cerebral vasospasm, moyamoya disease, and vasculitis. Dr. Kim’s research has been funded with grants from the FDA, Department of Defense, Washington Research Foundation, and NIH, including a recently awarded R01 from the NIH/NINDS. Dr. Kim holds several patents and pending patents pertaining to surgical robotics and minimally invasive endoscopic neurosurgery. He is also co-founder of Spi Surgical, Inc., a medical device and surgical robotics start-up. Part of this work led to the development and subsequent FDA approval of an endonasal pathway protection device known as Spiway, which is in clinical use today.Dr. Kim has published over 100 peer-reviewed articles in the areas of cerebral aneurysms, AVMs, dural AV fistulas, cavernous malformations, and complex microsurgical and endovascular technique. He has written numerous book chapters and editorials. He has been an invited lecturer and teacher throughout North and South America, Asia, and Europe.
Dr. Kim was elected to the Editorial Board of the Journal of Neurosurgery in 2017.
Sepideh Amin-Hanjani, MD
Dr. Sepideh Amin-Hanjani received her medical degree at Harvard Medical School and completed neurosurgery residency training at the Massachusetts General Hospital in Boston, Massachusetts, followed by a Cerebrovascular and Skull Base fellowship at the Barrow Neurological Institute in Phoenix, Arizona. She is currently tenured Professor and Residency Program Director in the Department of Neurosurgery at the University of Illinois at Chicago (UIC), where she serves as Co-Director of Neurovascular Surgery, with clinical work focused on treatment of cerebrovascular disease. Her longstanding research interests lie in the area of cerebrovascular blood flow and stroke, and she has held NIH funding as PI for a multi-site international study of blood flow in vertebrobasilar disease.
She is an active contributor to several national committees, including serving as the Vice-Chair of the AANS/ CNS Joint Guidelines Review Committee, and the Scientific Statements Oversight Committee of the American Heart Association Stroke Council. She has previously served as Chair of the AANS/CNS Cerebrovascular Section, and as a Member at Large of the CNS Executive Committee. Dr Amin-Hanjani became a Diplomate of the American Board of Neurological Surgery in 2004; she is also an elected member of the Society of Neurological Surgeons, the American Academy of Neurological Surgery and Society of University Neurosurgeons, a Fellow of the American Heart Association and American College of Surgeons, and serves as a Medical Advisory Board Regional Co-Director for the Brain Aneurysm Foundation. She has authored over 150 publications and 25 book chapters, and she participates in editorial review for multiple journals.
Dr. Amin-Hanjani was elected to the Editorial Board of the Journal of Neurosurgery in 2018.
Lynda Yang, MD
Dr. Lynda Yang received her medical research training through the NIH-Medical Scientist Training Program at the Johns Hopkins School of Medicine. She received her neurosurgery training from the University of Michigan and completed further peripheral nerve and brachial plexus surgery training with Dr. David Kline (LSU), Dr. Rolfe M. Birch (Orthopedics, Royal National Orthopedic Trust, UK), and Dr. Martijn Malessy (Neurosurgery, Leiden University Medical Center, NL). Dr. Yang’s research interests currently involve the furthering of evidence-based practice in peripheral nerve and brachial plexus surgery.
Dr. Yang is currently Professor in the Department of Neurosurgery and Director of the Brachial Plexus and Peripheral Nerve Program at the University of Michigan. She has served as Chairperson for the AANS/CNS Peripheral Nerve Division and in the organizational leadership in national and international peripheral nerve societies. She serves as member and/or past-chairperson on the Neurological Devices Advisory Panel in the Center for Devices and Radiological Health of the FDA.
Dr. Yang was elected to the Editorial Board of the Journal of Neurosurgery in 2018.
Dr. John A. Jane Jr., MD
Dr. John A. Jane Jr. is currently Professor of Neurosurgery and Pediatrics; Director of Pediatric Neurosurgery; Director of the Neuroendocrine Program; and Director of the Neurosurgery Residency Training Program at the University of Virginia. He received his B.A. at the University of Chicago, where he graduated with honors in 1992. He attended medical school at the University of Virginia, where he also completed his neurosurgical residency in 1997. After spending a year as a Fellow in Neurosurgery at Auckland Hospital in Auckland, New Zealand, he returned to UVA to finish his chief year in neurosurgery in 2003 with John A. Jane Sr. He then completed a pediatric neurosurgery fellowship, acting as the Chief Fellow of Pediatric Neurosurgery, at the Hospital for Sick Children in Toronto with Dr. James M. Drake.
In 2004 Dr. Jane Jr. joined the faculty at the University of Virginia as Assistant Professor and was named Director of the Division of Pediatric Neurosurgery, a practice that he shared with his father, John A. Jane Sr. In 2007, he was named Co-Director of the Neuroendocrine Program. He was promoted to Associate Professor in 2008, attained tenure in 2012, and became Professor in 2015. He became Director of the Neurosurgery residency training program in 2014.
In addition to his pediatric practice, Dr. Jane has a strong clinical and academic interest in the treatment of patients with pituitary and parasellar tumors, an interest that began under the tutelage of Dr. Edward R. Laws Jr. and continued with his colleague Dr. Edward H. Oldfield. He is an author of over 130 peer-reviewed publications on a variety of topics, including pituitary adenomas, craniopharyngiomas, craniosynostosis, Chiari malformations, hydrocephalus, and neurosurgical education and training.
Dr. Jane Jr. was elected to the Editorial Board of the Journal of Neurosurgery in 2018.
Mark Hamilton, MD
Dr. Mark Hamilton obtained his Bachelor of Science degree (with distinction) at the University of Toronto and then graduated from McGill University Medical School in 1983. He did his Neurosurgery Residency at the University of Calgary and received his FRCSC in 1991. He did fellowship training in cerebrovascular, skull base and pediatric neurosurgery at the Barrow Neurological Institute in Phoenix, Arizona, and joined the University of Calgary Department of Clinical Neurosciences in 1994, where he is currently a Professor of Neurosurgery with additional appointments in the Department of Surgery and the Department of Pediatrics. He was the Chief of the Division of Pediatric Neurosurgery from 2002 to 2011. He is head of the University of Calgary Adult Hydrocephalus Program, which he established, along with the University of Calgary Adult Hydrocephalus Clinic, in 2008. Dr. Hamilton is the chair of the Adult Hydrocephalus Clinical Research Network (AHCRN), which has eight clinical sites in three countries; President-Elect of the Hydrocephalus Society (International Society for Hydrocephalus and Cerebrospinal Fluid Disorders [ISHCSF]); and a member of the Board of Directors of the Hydrocephalus Association (HA) and the Medical Advisory Board (MAB) of the HA, as well a member of the Board of Directors of Hydrocephalus Canada. His current main clinical and research interests are the diagnosis and management of hydrocephalus in adults.
Dr. Hamilton was elected to the Editorial Board of the Journal of Neurosurgery in 2018.